GRAIL, Inc. Increase (Decrease) in Materials and Supplies
GRAIL, Inc. (GRAL) reported Increase (Decrease) in Materials and Supplies of $1.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInMaterialsAndSupplies · last filed 2026-08-06
- GRAIL, Inc. increase (decrease) in materials and supplies for the quarter ending 2026-06-30 was $569.00K, a 34.45% decline year-over-year.
- GRAIL, Inc. increase (decrease) in materials and supplies for the quarter ending 2026-03-31 was $1.18M, a 3361.76% increase year-over-year.
- GRAIL, Inc. increase (decrease) in materials and supplies for the quarter ending 2025-12-31 was -$2.16M.
- GRAIL, Inc. increase (decrease) in materials and supplies for the quarter ending 2025-09-30 was -$1.35M.
- GRAIL, Inc. increase (decrease) in materials and supplies for fiscal 2025 was -$2.62M.
- GRAIL, Inc. increase (decrease) in materials and supplies for fiscal 2024 was -$3.07M, a 258.40% decline from fiscal 2023.
- GRAIL, Inc. increase (decrease) in materials and supplies for fiscal 2023 was $1.94M, a 86.22% decline from fiscal 2023.
- GRAIL, Inc. increase (decrease) in materials and supplies for fiscal 2023 was $14.08M.
| Period end | Increase (Decrease) in Materials and Supplies 3 month | Increase (Decrease) in Materials and Supplies 6 month | Increase (Decrease) in Materials and Supplies 9 month | Increase (Decrease) in Materials and Supplies 12 month |
|---|---|---|---|---|
| 2026-06-30 | $569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.75M 10-Q · filed 2026-08-06 | -$417.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-07 | -$986.00K derived: sum of 2 quarters · filed 2026-05-07 | -$2.34M derived: sum of 3 quarters · filed 2026-05-07 | -$1.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.52M derived: sum of 2 quarters · filed 2026-03-12 | -$2.65M derived: sum of 3 quarters · filed 2026-08-06 | -$2.62M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$486.00K derived: sum of 2 quarters · filed 2026-08-06 | -$452.00K 10-Q · filed 2025-11-13 | -$3.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $868.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $902.00K 10-Q · filed 2026-08-06 | -$1.69M derived: sum of 3 quarters · filed 2026-08-06 | -$5.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-07 | -$2.56M derived: sum of 2 quarters · filed 2026-05-07 | -$6.85M derived: sum of 3 quarters · filed 2026-05-07 | -$2.92M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$6.88M derived: sum of 2 quarters · filed 2026-03-12 | -$2.96M derived: sum of 3 quarters · filed 2026-03-12 | -$3.07M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$4.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$365.00K derived: sum of 2 quarters · filed 2025-11-13 | -$482.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $3.81M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$117.00K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $1.94M 10-K · filed 2025-03-05 | |||
| 2023-01-01 | $14.08M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |